BAP1 immunohistochemistry and p16 FISH results in combination provide higher confidence in malignant pleural mesothelioma diagnosis: ROC analysis of the two tests
出版年份 2016 全文链接
标题
BAP1 immunohistochemistry and p16
FISH results in combination provide higher confidence in malignant pleural mesothelioma diagnosis: ROC analysis of the two tests
作者
关键词
-
出版物
PATHOLOGY INTERNATIONAL
Volume 66, Issue 10, Pages 563-570
出版商
Wiley
发表日期
2016-09-11
DOI
10.1111/pin.12453
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Utility of BAP1 Immunohistochemistry and p16 (CDKN2A) FISH in the Diagnosis of Malignant Mesothelioma in Effusion Cytology Specimens
- (2016) Harry C. Hwang et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Guidelines for the Cytopathologic Diagnosis of Epithelioid and Mixed-Type Malignant Mesothelioma
- (2015) Anders Hjerpe et al. ACTA CYTOLOGICA
- BAP1 Immunohistochemistry and p16 FISH to Separate Benign From Malignant Mesothelial Proliferations
- (2015) Brandon S. Sheffield et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Functional differences between wild-type and mutant-type BRCA1-associated protein 1 tumor suppressor against malignant mesothelioma cells
- (2015) Shuhei Hakiri et al. CANCER SCIENCE
- Deletion status ofp16in effusion smear preparation correlates with that of underlying malignant pleural mesothelioma tissue
- (2015) Tomoyuki Hida et al. CANCER SCIENCE
- BAP1 facilitates diagnostic objectivity, classification, and prognostication in malignant pleural mesothelioma
- (2015) Stephanie M. McGregor et al. HUMAN PATHOLOGY
- High Incidence of Somatic BAP1 Alterations in Sporadic Malignant Mesothelioma
- (2015) Masaki Nasu et al. Journal of Thoracic Oncology
- Targeted Next-Generation Sequencing of Cancer Genes in Advanced Stage Malignant Pleural Mesothelioma: A Retrospective Study
- (2015) Marco Lo Iacono et al. Journal of Thoracic Oncology
- Treatment patterns and survival analysis in 9014 patients with malignant pleural mesothelioma from Belgium, the Netherlands and England
- (2015) R.A. Damhuis et al. LUNG CANCER
- Loss of expression of BAP1 is a useful adjunct, which strongly supports the diagnosis of mesothelioma in effusion cytology
- (2015) Juliana Andrici et al. MODERN PATHOLOGY
- BAP1 (BRCA1-associated protein 1) is a highly specific marker for differentiating mesothelioma from reactive mesothelial proliferations
- (2015) Marta Cigognetti et al. MODERN PATHOLOGY
- Whole-Exome Sequencing Reveals Frequent Genetic Alterations in BAP1, NF2, CDKN2A, and CUL1 in Malignant Pleural Mesothelioma
- (2014) G. Guo et al. CANCER RESEARCH
- How useful is GLUT-1 in differentiating mesothelial hyperplasia and fibrosing pleuritis from epithelioid and sarcomatoid mesotheliomas? An international collaborative study
- (2014) Aliya N. Husain et al. LUNG CANCER
- Comparative Immunohistochemical Analysis of IMP3, GLUT1, EMA, CD146, and Desmin for Distinguishing Malignant Mesothelioma From Reactive Mesothelial Cells
- (2013) Hiroshi Minato et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- Morphology of 9p21 homozygous deletion-positive pleural mesothelioma cells analyzed using fluorescence in situ hybridization and virtual microscope system in effusion cytology
- (2013) Shinji Matsumoto et al. CANCER CYTOPATHOLOGY
- Treatment and survival analyses of malignant mesothelioma in Japan
- (2012) Kenichi Gemba et al. ACTA ONCOLOGICA
- Diagnostic Usefulness of p16/CDKN2A FISH in Distinguishing Between Sarcomatoid Mesothelioma and Fibrous Pleuritis
- (2012) Di Wu et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- IMP3 and GLUT-1 Immunohistochemistry for Distinguishing Benign From Malignant Mesothelial Proliferations
- (2012) Anna F. Lee et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Guidelines for Pathologic Diagnosis of Malignant Mesothelioma: 2012 Update of the Consensus Statement from the International Mesothelioma Interest Group
- (2012) Aliya N. Husain et al. ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE
- Frequent inactivation of the BAP1 gene in epithelioid-type malignant mesothelioma
- (2012) Yoshie Yoshikawa et al. CANCER SCIENCE
- BAP1 cancer syndrome: malignant mesothelioma, uveal and cutaneous melanoma, and MBAITs
- (2012) Michele Carbone et al. Journal of Translational Medicine
- The Diagnostic Utility ofp16FISH and GLUT-1 Immunohistochemical Analysis in Mesothelial Proliferations
- (2011) Sara E. Monaco et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- Oncofetal Protein IMP3, a New Diagnostic Biomarker to Distinguish Malignant Mesothelioma From Reactive Mesothelial Proliferation
- (2011) Min Shi et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Global mesothelioma deaths reported to the World Health Organization between 1994 and 2008
- (2011) Vanya Delgermaa et al. BULLETIN OF THE WORLD HEALTH ORGANIZATION
- Germline BAP1 mutation predisposes to uveal melanoma, lung adenocarcinoma, meningioma, and other cancers
- (2011) M. H. Abdel-Rahman et al. JOURNAL OF MEDICAL GENETICS
- The nuclear deubiquitinase BAP1 is commonly inactivated by somatic mutations and 3p21.1 losses in malignant pleural mesothelioma
- (2011) Matthew Bott et al. NATURE GENETICS
- Germline BAP1 mutations predispose to malignant mesothelioma
- (2011) Joseph R Testa et al. NATURE GENETICS
- Immunocytochemistry of CD146 is useful to discriminate between malignant pleural mesothelioma and reactive mesothelium
- (2010) Ayuko Sato et al. MODERN PATHOLOGY
- Identification of MCAM/CD146 as the Target Antigen of a Human Monoclonal Antibody that Recognizes Both Epithelioid and Sarcomatoid Types of Mesothelioma
- (2009) Scott Bidlingmaier et al. CANCER RESEARCH
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now